Tuesday, March 17, 2026

No More Dialogue, Says Kim Jong Un, as He Blames Lee for Escalating Tensions

Kim Jong Un asserts no engagement with South Korea, emphasizing their separation and hostility, while criticizing military actions.

North Korean Defector’s Son Pleads for Help as Mother Faces Forced Repatriation from China

A North Korean defector's family pleads for help as their mother faces forced repatriation from China, risking severe human rights violations.

NVIDIA Stock Soars Nearly 9% After Sharp 17% Drop, Boosting Market Value to $3.16 Trillion

Nvidia rebounds nearly 9% after a 17% drop, driven by low-cost buying, amid shock from China's AI firm DeepSeek.

Tag: Samsung Bioepis

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

Samsung Bioepis Expands SB15 Eylea Rival: Licensing Pact Targets Global Markets as Original Drug Hits $10.5B Sales

Samsung Bioepis has secured a licensing deal for its ophthalmic treatment SB15, expanding access in international markets outside the US and Canada.

Samsung Bioepis Taps Harrow to Take Over U.S. Ophthalmic Drug Rights from Biogen

Samsung Bioepis partners with Harrow to sell ophthalmic treatments in the U.S., transferring rights from Biogen by 2025.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.